Related Experiment Videos
Acute respiratory illness in children with acute lymphoblastic leukemia
Insights
A significant percentage of children with acute lymphoblastic leukemia developed severe lung inflammation after central nervous system prophylaxis. Early diagnosis and supportive care are crucial for managing this potentially fatal complication.
Area of Science:
- Pediatric Oncology
- Pulmonology
- Infectious Diseases
Background:
- Acute lymphoblastic leukemia (ALL) treatment involves central nervous system (CNS) prophylaxis.
- Immunosuppression during ALL therapy can increase infection risk.
- Interstitial pneumonitis is a serious complication observed in some pediatric ALL patients.
Purpose of the Study:
- To investigate the incidence and characteristics of severe interstitial pneumonitis in children undergoing CNS prophylactic therapy for ALL.
- To determine the likely etiology and outcomes of this pneumonitis.
- To emphasize the importance of early recognition and management.
Main Methods:
- Retrospective analysis of 70 children with ALL.
- Clinical data collection including symptoms, onset, and resolution of pneumonitis.
- Review of lung tissue for causative organisms (e.g., P. carinii).
Main Results:
- 14% (10 of 70) of children developed severe interstitial pneumonitis within three weeks of CNS prophylaxis.
- Symptoms included fever, cough, dyspnea, and hypoxemia.
- Pneumonitis resolved in most cases, but one patient died from respiratory failure; P. carinii was identified in only one case, suggesting a likely viral etiology in others.
Conclusions:
- Severe interstitial pneumonitis is a significant risk in pediatric ALL patients receiving CNS prophylaxis.
- The condition is likely viral in origin, exacerbated by lymphopenia and immunosuppression.
- Prompt diagnosis via open lung biopsy and aggressive supportive care are essential to reduce morbidity and mortality.
Abstract:
Ten of 70 children (14%) with acute lymphoblastic leukemia developed severe interstitial pneumonitis within three weeks after induction of central nervous system prophylactic therapy. The clinical picture was characterized by fever, cough, progressive dyspnea, and hypoxemia with complete resolution in one to three weeks, except in one patient who died during the acute illness from respiratory failure. P. carinii organisms were found in the lung tissue of only one patient. The etiology of the pneumonitis in the other nine children was probably viral, acquired or activated during a period of lymphopenia and immunosuppression. The morbidity and potential mortality from the pneumonitis warrants early recognition by open lung biopsy and intensive supportive therapy.